Galaxy Diagnostics said this week that it has opened a clinical testing laboratory in Research Triangle Park, NC, to expand the availability of its PCR-based test for Bartonella, a difficult-to-detect species of bacteria that causes a variety of animal and human diseases, the most well known of which is cat-scratch disease.

Galaxy's new laboratory is in the Alexandria Innovation Center in Research Triangle Park, where the company moved after recently graduating from the First Flight Venture Center, a technology incubator also located in RTP.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.